Shanghai Hile Bio-Technology Co., Ltd. (603718.SS)

CNY 7.45

(0.0%)

Total Assets Summary of Shanghai Hile Bio-Technology Co., Ltd.

  • Shanghai Hile Bio-Technology Co., Ltd.'s latest annual total assets in 2023 was 1.65 Billion CNY , up 9.48% from previous year.
  • Shanghai Hile Bio-Technology Co., Ltd.'s latest quarterly total assets in 2024 Q2 was 1.6 Billion CNY , down -2.55% from previous quarter.
  • Shanghai Hile Bio-Technology Co., Ltd. reported annual total assets of 1.51 Billion CNY in 2022, down -17.89% from previous year.
  • Shanghai Hile Bio-Technology Co., Ltd. reported annual total assets of 1.84 Billion CNY in 2021, up 3.21% from previous year.
  • Shanghai Hile Bio-Technology Co., Ltd. reported quarterly total assets of 1.64 Billion CNY for 2024 Q1, down -0.76% from previous quarter.
  • Shanghai Hile Bio-Technology Co., Ltd. reported quarterly total assets of 1.6 Billion CNY for 2024 Q2, down -2.55% from previous quarter.

Annual Total Assets Chart of Shanghai Hile Bio-Technology Co., Ltd. (2023 - 2011)

Historical Annual Total Assets of Shanghai Hile Bio-Technology Co., Ltd. (2023 - 2011)

Year Total Assets Total Assets Growth
2023 1.65 Billion CNY 9.48%
2022 1.51 Billion CNY -17.89%
2021 1.84 Billion CNY 3.21%
2020 1.78 Billion CNY 5.02%
2019 1.7 Billion CNY -2.7%
2018 1.74 Billion CNY 9.17%
2017 1.6 Billion CNY 8.23%
2016 1.47 Billion CNY 19.32%
2015 1.24 Billion CNY 89.51%
2014 654.47 Million CNY 8.93%
2013 600.83 Million CNY 7.17%
2012 560.66 Million CNY 11.23%
2011 504.03 Million CNY 0.0%

Peer Total Assets Comparison of Shanghai Hile Bio-Technology Co., Ltd.

Name Total Assets Total Assets Difference
Beijing Tiantan Biological Products Co., Ltd. 14.18 Billion CNY 88.316%
JiangSu WuZhong Pharmaceutical Development Co., Ltd. 4.32 Billion CNY 61.687%
Jinyu Bio-technology Co., Ltd. 6.87 Billion CNY 75.879%
Vcanbio Cell & Gene Engineering Corp., Ltd 5.41 Billion CNY 69.365%
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong 14.38 Billion CNY 88.476%
Zhejiang Ausun Pharmaceutical Co., Ltd. 2.95 Billion CNY 43.835%
DaShenLin Pharmaceutical Group Co., Ltd. 24.12 Billion CNY 93.128%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. 15.71 Billion CNY 89.451%
GuiZhou SanLi Pharmaceutical Co.,Ltd 2.92 Billion CNY 43.237%
Pulike Biological Engineering, Inc. 3.26 Billion CNY 49.183%
Beijing Konruns Pharmaceutical Co.,Ltd. 3.78 Billion CNY 56.154%
Qingdao Vland Biotech INC. 3.03 Billion CNY 45.362%
Zhejiang Shouxiangu Pharmaceutical Co., Ltd. 3.17 Billion CNY 47.777%
Aurisco Pharmaceutical Co.,Ltd. 2.57 Billion CNY 35.612%
Zhejiang East Asia Pharmaceutical Co., Ltd. 3.34 Billion CNY 50.416%
Hainan Huluwa Pharmaceutical Group Co., Ltd. 3.06 Billion CNY 45.835%
Mabwell (Shanghai) Bioscience Co., Ltd. 4.45 Billion CNY 62.789%
Beijing Hotgen Biotech Co., Ltd. 3.56 Billion CNY 53.442%
Assure Tech (Hangzhou) Co., Ltd. 5.78 Billion CNY 71.366%
Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. 3.54 Billion CNY 53.267%
Cabio Biotech (Wuhan) Co., Ltd. 1.61 Billion CNY -2.87%
Shanghai Shen Lian Biomedical Corporation 1.59 Billion CNY -4.0%
Nanjing Vazyme Biotech Co., Ltd. 5.74 Billion CNY 71.15%
Shandong Kexing Bioproducts Co,.Ltd 3.03 Billion CNY 45.309%
Shanghai Junshi Biosciences Co., Ltd. 11.34 Billion CNY 85.385%
Shanghai Model Organisms Center, Inc. 1.99 Billion CNY 17.02%
Suzhou Zelgen Biopharmaceuticals Co., Ltd. 2.88 Billion CNY 42.583%
Xiamen Amoytop Biotech Co., Ltd. 2.35 Billion CNY 29.64%
Novogene Co., Ltd. 3.59 Billion CNY 53.88%
Shanghai ZJ Bio-Tech Co., Ltd. 4.07 Billion CNY 59.311%
Chengdu Olymvax Biopharmaceuticals Inc. 1.61 Billion CNY -2.799%
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd 5.3 Billion CNY 68.751%
Shanghai Haohai Biological Technology Co., Ltd. 7.1 Billion CNY 76.669%
Jiangsu Bioperfectus Technologies Co., Ltd. 3.9 Billion CNY 57.563%
Jiangsu Aidea Pharmaceutical Co., Ltd. 1.74 Billion CNY 5.085%
Chengdu Easton Biopharmaceuticals Co., Ltd. 3.34 Billion CNY 50.467%
Sinocelltech Group Limited 2.71 Billion CNY 39.02%
Wuhan Keqian Biology Co.,Ltd 4.67 Billion CNY 64.512%
Shanghai Allist Pharmaceuticals Co., Ltd. 4.37 Billion CNY 62.122%
Anhui Huaheng Biotechnology Co., Ltd. 3.97 Billion CNY 58.246%
Youcare Pharmaceutical Group Co., Ltd. 5.91 Billion CNY 71.956%
Jiangsu gdk Biotechnology Co., Ltd. 1.63 Billion CNY -1.603%
Beijing Kawin Technology Share-Holding Co., Ltd. 2.44 Billion CNY 32.287%
Hangzhou Biotest Biotech Co.,Ltd. 2.57 Billion CNY 35.735%